tiprankstipranks
Trending News
More News >
Trump urges drugmakers to accept lower prices on prescriptions, Bloomberg says
PremiumThe FlyTrump urges drugmakers to accept lower prices on prescriptions, Bloomberg says
7d ago
Johnson & Johnson announces new data from Phase 3 QUASAR study of tremfya
Premium
The Fly
Johnson & Johnson announces new data from Phase 3 QUASAR study of tremfya
7d ago
Johnson & Johnson announces new data from Phase 3 ASTRO study of tremfya
Premium
The Fly
Johnson & Johnson announces new data from Phase 3 ASTRO study of tremfya
7d ago
Johnson & Johnson price target raised to $184 from $180 at HSBC
PremiumThe FlyJohnson & Johnson price target raised to $184 from $180 at HSBC
14d ago
Johnson & Johnson’s Strategic Advancements in Electrophysiology: A Buy Rating by Josh Jennings
Premium
Ratings
Johnson & Johnson’s Strategic Advancements in Electrophysiology: A Buy Rating by Josh Jennings
14d ago
Johnson & Johnson announces new data from Cohort 2 of Phase 2b SunRISe-1
Premium
The Fly
Johnson & Johnson announces new data from Cohort 2 of Phase 2b SunRISe-1
15d ago
Unusually active option classes on open April 17th
PremiumThe FlyUnusually active option classes on open April 17th
25d ago
Johnson & Johnson price target lowered to $165 from $166 at Barclays
Premium
The Fly
Johnson & Johnson price target lowered to $165 from $166 at Barclays
25d ago
Addex Therapeutics regains rights to ADX71149
Premium
The Fly
Addex Therapeutics regains rights to ADX71149
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100